Matches in Wikidata for { <http://www.wikidata.org/entity/Q94424927> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q94424927 description "article scientifique publié en 2016" @default.
- Q94424927 description "wetenschappelijk artikel" @default.
- Q94424927 description "наукова стаття" @default.
- Q94424927 name "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer" @default.
- Q94424927 name "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer" @default.
- Q94424927 type Item @default.
- Q94424927 label "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer" @default.
- Q94424927 label "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer" @default.
- Q94424927 prefLabel "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer" @default.
- Q94424927 prefLabel "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer" @default.
- Q94424927 P1433 Q94424927-F8BA7BDA-1DDB-43DE-9C6C-9F34CFCF979C @default.
- Q94424927 P1476 Q94424927-77EC4073-4742-4D98-85FE-AACDEB7773DD @default.
- Q94424927 P2093 Q94424927-0B6EE1B4-92B0-428A-B248-7E9A1D9BC563 @default.
- Q94424927 P2093 Q94424927-0F7AAF57-6220-49CD-AC80-DDF0AD02B883 @default.
- Q94424927 P2093 Q94424927-13FA509F-6F27-4C0A-9ECE-636C1F5E7B4B @default.
- Q94424927 P2093 Q94424927-1FDDC901-F9EF-4A1D-8180-2162EA59C5E5 @default.
- Q94424927 P2093 Q94424927-23E73D66-BBD9-4781-9CA5-64E2180F1B2C @default.
- Q94424927 P2093 Q94424927-25952DEB-677D-4521-BB42-63235DD0A52A @default.
- Q94424927 P2093 Q94424927-2A758854-173D-4304-B6FF-2A03C0B46A19 @default.
- Q94424927 P2093 Q94424927-2F973231-F5DB-4BE7-985A-3F6178F9EEE5 @default.
- Q94424927 P2093 Q94424927-320F31B6-EB9C-4DBF-8F0F-02A7E08D1140 @default.
- Q94424927 P2093 Q94424927-4F94E6C7-BDFC-4633-B4E2-E0D1BACE45DC @default.
- Q94424927 P2093 Q94424927-5761A2F1-A4F9-4976-AB41-F17BCAE166DB @default.
- Q94424927 P2093 Q94424927-6E96212D-704E-4297-8735-C14C8EF165CD @default.
- Q94424927 P2093 Q94424927-6FD44B7C-5D9D-478F-97BC-626BC0CC4075 @default.
- Q94424927 P2093 Q94424927-93696405-DDC2-49CA-A097-CBD8272CF011 @default.
- Q94424927 P2093 Q94424927-B8687776-B00D-43C8-AA40-57BCA71CE085 @default.
- Q94424927 P2093 Q94424927-C2377092-E9B1-4832-9372-8CDA730A17FC @default.
- Q94424927 P2093 Q94424927-C544D0F9-5D8C-4B73-922F-1C8721198373 @default.
- Q94424927 P2093 Q94424927-D1B05A76-8CF4-4245-91BC-64C14C4FFBDE @default.
- Q94424927 P2093 Q94424927-E9904510-9F71-4A15-8B81-7B2BC673DA9D @default.
- Q94424927 P2093 Q94424927-EB8DDC9F-5D9F-4610-BD17-35CF66CD2B8C @default.
- Q94424927 P2093 Q94424927-F6858CA5-0453-4BB3-891E-AB77820685F2 @default.
- Q94424927 P2093 Q94424927-FDE0B42F-AF4C-447E-BF80-45A798E5C18A @default.
- Q94424927 P304 Q94424927-FB6A2F68-B68C-492A-8B87-A5BA563091B2 @default.
- Q94424927 P31 Q94424927-ED5BE68D-B573-43E0-A8AC-6DB2180CEEDB @default.
- Q94424927 P356 Q94424927-0FB1E820-7109-4272-B7BD-F3C5F0299EC6 @default.
- Q94424927 P433 Q94424927-1C5ECEB6-F2B4-48C5-9C2C-8D1FB2FC3CEA @default.
- Q94424927 P478 Q94424927-80A24352-6A89-46C1-8671-F7E8DCE04BD9 @default.
- Q94424927 P577 Q94424927-FF35505A-8472-45B2-85A8-CBE8962A6DC2 @default.
- Q94424927 P921 Q94424927-3DB10A11-165F-494E-BB82-F816B583759A @default.
- Q94424927 P921 Q94424927-786B8074-9C63-4339-B9A3-E794206D9E07 @default.
- Q94424927 P932 Q94424927-CC8ADDED-FEFF-4899-B202-5B50E07F3941 @default.
- Q94424927 P356 MDW200.11 @default.
- Q94424927 P1433 Q326122 @default.
- Q94424927 P1476 "PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC)" @default.
- Q94424927 P2093 "A. Starodub" @default.
- Q94424927 P2093 "A. Tsimberidou" @default.
- Q94424927 P2093 "D. Adib" @default.
- Q94424927 P2093 "D. Jäger" @default.
- Q94424927 P2093 "D. Mahalingam" @default.
- Q94424927 P2093 "G. Manzur" @default.
- Q94424927 P2093 "J. Nemunaitis" @default.
- Q94424927 P2093 "J. Sachdev" @default.
- Q94424927 P2093 "J. Sarantopoulos" @default.
- Q94424927 P2093 "K. Sivarajan" @default.
- Q94424927 P2093 "L. Hart" @default.
- Q94424927 P2093 "M. Jones" @default.
- Q94424927 P2093 "M. Patel" @default.
- Q94424927 P2093 "M. Wertheim" @default.
- Q94424927 P2093 "M. Yoon" @default.
- Q94424927 P2093 "N. Halama" @default.
- Q94424927 P2093 "P. Thambi" @default.
- Q94424927 P2093 "R. Kerschbaumer" @default.
- Q94424927 P2093 "R. Ramanathan" @default.
- Q94424927 P2093 "S. Goel" @default.
- Q94424927 P2093 "S. Yazji" @default.
- Q94424927 P2093 "X. Liu" @default.
- Q94424927 P304 "ii105-ii105" @default.
- Q94424927 P31 Q13442814 @default.
- Q94424927 P356 "10.1093/ANNONC/MDW200.11" @default.
- Q94424927 P433 "Suppl 2" @default.
- Q94424927 P478 "27" @default.
- Q94424927 P577 "2016-06-21T00:00:00Z" @default.
- Q94424927 P921 Q108566365 @default.
- Q94424927 P921 Q188874 @default.
- Q94424927 P932 "4984159" @default.